[Finished Printing? - Click Here to Return to Normal View]


NIDA Home > About NIDA > Organization   

Initial Review Group (IRG) and Special Emphasis Panel (SEP)
gray line



National Institute on Drug Abuse Initial Review Group and Special Emphasis Panel Meeting Dates for 2004

[Hotel Information] [Contact Information] [IRG Structure Page]

Meetings: [Feb. March & April 2004] [June & July 2004] [Oct. Nov. & Dec. 2004]

Rosters: [NIDA/E, NIDA/F, NIDA/K, NIDA/L, ZDA1 (e.g. RFA, C01, etc)]


February, March & April 2004

2/23-24 ZDA1-RXL-E-23 (Centers)
Ritz Carlton at Pentagon City
3/1
NIDA/L
Westin Grand
3/1
ZDA1-EXL-T-26 (Medication Development Conflicts)
Westin Grand
3/2-3
NIDA/E
Hyatt Regency Bethesda
3/2-3
NIDA/F
Hyatt Regency Bethesda
3/3
ZDA1-TXL-Q-24 (Members Conflicts)
Hyatt Regency Bethesda
3/3
ZDA1-KXN-G-28 (Maternal Opioid Treatment)
Hyatt Regency Bethesda
3/9-11
NIDA/K
Bethesda Residence Inn
3/10
ZDA1-EXL-T-34 (Training and Career Development Conflicts)
Bethesda Residence Inn
3/14-16
ZDA1-RXL-E-21 (RFA-DA-04-004-NIDA Neuroproteomics Research Centers [NIDA NPRCs])
Ritz Carlton at Pentagon City
3/22
ZDA1-KXA-N-22 (Centers) DoubleTree Rockville
3/24
ZDA1-MXG-S-37
OEA, NIDA, 6101 Executive Blvd.
3/31
ZDA1-EXL-T-25 (Program Projects)
Bethesda Residence Inn
4/20
ZDA1-TXL-Q-36 (Member Conflict)
OEA, NIDA, 6101 Executive Blvd.
4/21
ZDA1-TXL-Q-38 (Member Conflict)
OEA, NIDA, 6101 Executive Blvd.
4/21
ZDA1-TXL-Q-37 (Member Conflict)
OEA, NIDA, 6101 Executive Blvd.

June & July 2004

6/2-3
ZDA1-MXG-S-05 (RFA-DA-04-009-Behavioral & Cognitive Processes Related to Adolescent Drug Abuse)
Residence Inn Bethesda
6/7
NIDA/L
The Fairmont Washington
6/8-9
NIDA/E
Hyatt Regency Bethesda
6/8-9
NIDA/F
Hyatt Regency Bethesda
6/8
ZDA1-MXG-S-07 (Member Conflict A)
Hyatt Regency Bethesda
6/9
ZDA1-MXG-S-19 (Member Conflict B)
Hyatt Regency Bethesda
6/29-30
ZDA1-MXS-M-12 (RFA-DA-04-012-HIV/AIDS, Drug Use, and Highly Vulnerable Youth: Targeting Research Gaps)
Residence Inn Bethesda
6/30
ZDA1-EXL-T-10 (RFA-DA-04-010-Targeted Integrative Research in Drug Abuse and HIV/AIDS in Pregnancy)
OEA, NIDA, 6101 Executive Blvd
7//7-8
ZDA1-MXG-S-03 (RFA-DA-04-006-Screening and Intervention for Youth in Primary Care Settings)
Hyatt Regency Bethesda
7/8
ZDA1-EXL-T-18 (Member Conflict) Ritz Carlton at Pentagon City
7/7-9
NIDA/K
Ritz Carlton at Pentagon City
7/12
ZDA1-RXL-E-20 (Centers)
Ritz Carlton at Pentagon City
7/14-15
ZDA1-MXS-M-11 (RFA-DA-04-011-Animal Models of Adolescent Drug abuse: Integrative Studies of Brain and Behavioral Development)
The Fairmont Washington
7/15
ZDA1-KXA-N-14 (RFA-DA-04-014-Medications Development for Cannabis-Related Disorder)
Bethesda Marriott Hotel
7/22-23
ZDA1-KXN-G-04 (RFA-DDA-04-008-Group Therapy for Individuals in Drug Abuse or Alcoholism Treatment)
Radisson Barcello Hotel

October, November & December 2004

10/5-6
NIDA/E
Hyatt Regency Bethesda
10/5-6
NIDA/F
Hyatt Regency Bethesda
10/12
NIDA/L
TBA
11/8-9
ZDA1-RXL-E (Centers)
Ritz Carlton at Pentagon City
11/16-18
NIDA/K
Ritz Carlton at Pentagon City



National Institute on Drug Abuse Initial Review Groups (IRGs) and Scientific Review Administrators (SRAs):

Flex Code Name of Subcommittee Scientific Review Administrator
NIDA/E Treatment Research Subcommittee Kesinee Nimit, M.D.
301-435-1432
NIDA/F Health Services Research Subcommittee Mark Green, Ph.D.
301-435-1431
NIDA/K Training and Career Development Subcommittee Mark Swieter, Ph.D.
301-435-1389
NIDA/L Medication Development Research Subcommittee Khursheed Asghar, Ph.D.
301-443-2620



National Institute on Drug Abuse Special Emphasis Panels (SEPs) and Scientific Review Administrators (SRAs):

Flex Code Scientific Review Administrator Phone Number
ZDA1-EXL-T Eliane Lazar-Wesley, Ph.D. 301-451-4530
ZDA1-KXA-N Khursheed Asghar, Ph.D. 301-443-2620
ZDA1-KXN-G Kesinee Nimit, M.D. 301-435-1432
ZDA1-MXG-S Mark Green, Ph.D. 301-435-1431
ZDA1-MXS-M Mark Swieter, Ph.D. 301-435-1389
ZDA1-RXL-E Rita Liu, Ph.D. 301-435-1388
ZDA1-TXL-Q Teresa Levitin, Ph.D. 301-443-2755


Hotels (Address and Telephone Numbers)

Bethesda Marriott Hotel
5151 Pooks Hill Road
Bethesda, MD 20814
301-897-9400, Ext. 6034
Toll Free Reservation Center 800-228-9290

Double Tree Hotel
1750 Rockville Pike
Rockville, MD 20852
301-468-1100

The Fairmont Washington, D.C.
2401 M Street
N.W., Washington, DC 20037
202-429-2400

Hyatt Regency Bethesda
One Bethesda Metro Center
Bethesda, MD 20814
301-657-1234

Radisson Barcelo Hotel
2121 P Street N.W.
Washington, DC 20037
202-293-3100

Residence Inn by Marriot
7335 Wisconsin Avenue
Bethesda, MD 20814
301-718-0200

Ritz-Carlton Hotel at Pentagon City
1250 South Hayes Street
Arlington, VA 22202
703-415-5000

The Westin Grand Hotel
2350 M Street
NW, Washington, DC 20039
202-429-0100


For general committee information contact:

Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384
chollan1@nida.nih.gov.

For specific committee information contact the Scientific Review Administrator listed above.

Office Address:

Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
Atrium Building
6101 Executive Boulevard
Room 220, MSC 8401
Bethesda, Maryland 20892-8401


About NIDA Contents



Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment | Print Version
National Institutes of Health logo Department of Health and Human Services Logo

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, June 21, 2004.